DANIELLE POULOS: Open Payments
NPI 1447995352 · PALOS PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$355 in 13 payments from 8 companies in 2025. Trend: 2023 $205 · 2024 $490 · 2025 $355
Food & beverage: $355
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 1 | $95 |
| Novo Nordisk Inc | 3 | $83 |
| PFIZER INC. | 2 | $49 |
| Alnylam Pharmaceuticals Inc. | 2 | $47 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| Octapharma USA, Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: SAPIEN 3 Ultra RESILIA, Wegovy, LEQVIO, ELIQUIS, ONPATTRO, VYNDAQEL, AMVUTTRA, BALFAXAR.
Industry payments across IL — which companies pay providers there.
